Related references
Note: Only part of the references are listed.The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community
Yihienew M. Bezabih et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Longitudinal analysis of ESBL and carbapenemase carriage among Enterobacterales and Pseudomonas aeruginosa isolates collected in Europe as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme, 2013-17
Krystyna M. Kazmierczak et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016
Helio S. Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Past and Present Perspectives on β-Lactamases
Karen Bush
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype
Edward R. Bevan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis
Styliani Karanika et al.
CLINICAL INFECTIOUS DISEASES (2016)
Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014
Sibylle H. Lob et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
The Continuing Plague of Extended-spectrum β-lactamase-producing Enterobacteriaceae Infections
Amos Adler et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013
Shio-Shin Jean et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia
Helio S. Sader et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Antimicrobial resistance and resistance mechanisms of Enterobacteriaceae in ICU and non-ICU wards in Europe and North America: SMART 2011-2013
S. H. Lob et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2015)
Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011
Stephen Hawser et al.
JOURNAL OF CHEMOTHERAPY (2015)
A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011
Ian Morrissey et al.
PHARMACEUTICALS (2013)
Incidence and Antimicrobial Susceptibility of Escherichia coli and Klebsiella pneumoniae with Extended-Spectrum β-Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)
Stephen P. Hawser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Share Paper
